Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entity represents a **pseudogene similar to V-set and immunoglobulin domain containing 6 (VSIG6)**. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from duplication or retrotransposition of functional genes followed by mutations resulting in loss of protein-coding ability or regulatory elements. The functional VSIG family (which includes VSIG1, VSIG3, VSIG4, etc.) encodes immune-related proteins such as immune checkpoint molecules, but the pseudogene described here (ENSG00000260218) is not transcribed into a functional protein and has no known physiological or therapeutic relevance[3][2]. **Note:** There is no evidence this pseudogene encodes a protein, acts as a receptor or enzyme, or is currently targeted by any drugs or considered in therapeutic applications. Pseudogenes are generally not considered molecular targets, and therefore most requested fields are not applicable in this case[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on V-set and immunoglobulin domain containing 6 pseudogene.